Status:
WITHDRAWN
Safety and Preliminary Efficacy Study of PDS-1.0 in Patients With Neovascular AMD
Lead Sponsor:
Forsight Vision4
Conditions:
Age-Related Macular Degeneration
Eligibility:
All Genders
50+ years
Phase:
PHASE1
Brief Summary
This study will evaluate the safety and preliminary effectiveness of PDS 1.0 in patients with neovascular AMD.
Eligibility Criteria
Inclusion
- Key
- Diagnosis of CNV secondary to AMD confirmed by fluorescein angiography, not previously treated
- Retinal thickness due to edema of at least 300um in the study eye
- Best corrected visual acuity of 20/80 or worse in the study eye
- Best corrected visual acuity of 20/40 or better in the fellow eye
Exclusion
- Evidence of scarring CNV (e.g. geographic atrophy) in the study eye
- Fibrosis \>75% of lesion area in the study eye
Key Trial Info
Start Date :
January 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT01177644
Start Date
January 1 2011
Last Update
August 22 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tel Aviv, Israel